These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 13678472)

  • 1. Potent suppression of HIV type 1 infection by a short hairpin anti-CXCR4 siRNA.
    Anderson J; Banerjea A; Planelles V; Akkina R
    AIDS Res Hum Retroviruses; 2003 Aug; 19(8):699-706. PubMed ID: 13678472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bispecific short hairpin siRNA constructs targeted to CD4, CXCR4, and CCR5 confer HIV-1 resistance.
    Anderson J; Banerjea A; Akkina R
    Oligonucleotides; 2003; 13(5):303-12. PubMed ID: 15000821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4.
    Zhou N; Fang J; Mukhtar M; Acheampong E; Pomerantz RJ
    Gene Ther; 2004 Dec; 11(23):1703-12. PubMed ID: 15306840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector.
    Anderson J; Akkina R
    AIDS Res Ther; 2005 Jan; 2(1):1. PubMed ID: 15813990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication.
    Martínez MA; Gutiérrez A; Armand-Ugón M; Blanco J; Parera M; Gómez J; Clotet B; Esté JA
    AIDS; 2002 Dec; 16(18):2385-90. PubMed ID: 12461411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR4 and CCR5 shRNA transgenic CD34+ cell derived macrophages are functionally normal and resist HIV-1 infection.
    Anderson J; Akkina R
    Retrovirology; 2005 Aug; 2():53. PubMed ID: 16109172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of CXCR4 expression by SDF-KDEL in CD34(+) hematopoietic stem cells: An anti-human immunodeficiency virus strategy.
    Zhang JC; Sun L; Nie QH; Huang CX; Jia ZS; Wang JP; Lian JQ; Li XH; Wang PZ; Zhang Y; Zhuang Y; Sun YT; Bai X
    J Virol Methods; 2009 Oct; 161(1):30-7. PubMed ID: 19463855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable gene transfer of CCR5 and CXCR4 siRNAs by sleeping beauty transposon system to confer HIV-1 resistance.
    Tamhane M; Akkina R
    AIDS Res Ther; 2008 Jul; 5():16. PubMed ID: 18667075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of CXCR4 expression in MT4 cells by a recombinant vector expressing antisense RNA to CXCR4 and its potential anti-HIV-1 effect.
    Xing HC; Xu XY; Liu Z; Wang QH; Yu M; Si CW
    Jpn J Infect Dis; 2004 Jun; 57(3):91-6. PubMed ID: 15218216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection.
    Anderson J; Akkina R
    Gene Ther; 2007 Sep; 14(17):1287-97. PubMed ID: 17597795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of HIV-1 gene expression by siRNAs in transduced cells.
    Hayafune M; Miyano-Kurosaki N; Takaku H; Park WS
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(7):795-9. PubMed ID: 16898417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of lipoplex surface charge on siRNA delivery: application to the in vitro downregulation of CXCR4 HIV-1 co-receptor.
    Lavigne C; Slater K; Gajanayaka N; Duguay C; Arnau Peyrotte E; Fortier G; Simard M; Kell AJ; Barnes ML; Thierry AR
    Expert Opin Biol Ther; 2013 Jul; 13(7):973-85. PubMed ID: 23289797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGFA Gene Silencing in CXCR4-Expressing Cells via siRNA Delivery by Means of Targeted Peptide Carrier.
    Egorova AA; Maretina MA; Kiselev AV
    Methods Mol Biol; 2019; 1974():57-68. PubMed ID: 31098995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a cell-based enzyme-linked immunosorbent assay for high-throughput screening of HIV type 1 entry inhibitors targeting the coreceptor CXCR4.
    Zhao Q; Lu H; Schols D; De Clercq E; Jiang S
    AIDS Res Hum Retroviruses; 2003 Nov; 19(11):947-55. PubMed ID: 14678601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of HIV-1 gene expression by two types of siRNA expression systems.
    Hayafune M; Miyano-Kurosaki N; Park WS; Moori Y; Takaku H
    Antivir Chem Chemother; 2006; 17(5):241-9. PubMed ID: 17176628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The two human CXCR4 isoforms display different HIV receptor activities: consequences for the emergence of X4 strains.
    Duquenne C; Psomas C; Gimenez S; Guigues A; Carles MJ; Barbuat C; Lavigne JP; Sotto A; Reynes J; Guglielmi P; Mettling C; François V; Corbeau P
    J Immunol; 2014 Oct; 193(8):4188-94. PubMed ID: 25230750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of HIV-1 infection by down-regulation of the CXCR4 co-receptor using an intracellular single chain variable fragment against CXCR4.
    BouHamdan M; Strayer DS; Wei D; Mukhtar M; Duan LX; Hoxie J; Pomerantz RJ
    Gene Ther; 2001 Mar; 8(5):408-18. PubMed ID: 11313818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol enhances HIV type 1 infection in normal human oral keratinocytes by up-regulating cell-surface CXCR4 coreceptor.
    Chen H; Zha J; Gowans RE; Camargo P; Nishitani J; McQuirter JL; Cole SW; Zack JA; Liu X
    AIDS Res Hum Retroviruses; 2004 May; 20(5):513-9. PubMed ID: 15186526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic zinc-dithiocarbamate-S,S'-dioxide blocks CXCR4-mediated HIV-1 infection.
    Takamune N; Misumi S; Shoji S
    Biochem Biophys Res Commun; 2000 Jun; 272(2):351-6. PubMed ID: 10833417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy.
    Bai J; Rossi J; Akkina R
    AIDS Res Hum Retroviruses; 2001 Mar; 17(5):385-99. PubMed ID: 11282007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.